首页|支气管肺泡灌洗辅助治疗重症肺炎合并呼吸衰竭的疗效及对炎性因子、肺功能的影响

支气管肺泡灌洗辅助治疗重症肺炎合并呼吸衰竭的疗效及对炎性因子、肺功能的影响

扫码查看
目的 探讨对重症肺炎合并呼吸衰竭予支气管肺泡灌洗辅助治疗的临床疗效及对炎性因子、肺功能的改善作用.方法 60 例重症肺炎合并呼吸衰竭患者,以随机数字表法分为对照组与观察组,每组 30 例.对照组给予常规治疗,观察组在对照组基础上联合支气管肺泡灌洗辅助治疗.比较两组临床疗效及机械通气时间、重症加强护理病房(ICU)治疗时间,治疗前后炎性因子[C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)]、血气指标[血氧分压(PaO2)、二氧化碳分压(PaCO2)、血氧饱和度(SaO2)、氧合指数(PaO2/FiO2)]以及肺功能指标[第 1 秒用力呼气容积(FEV1)、呼气流量峰值(PEF)、第 1 秒用力呼气量占用力肺活量百分比(FEV1/FVC)].结果 观察组临床总有效率高于对照组(90.00%vs 66.67%,P<0.05).观察组机械通气时间与ICU治疗时间分别为(6.29±1.67)、(8.52±2.53)d,均短于对照组的(8.53±2.24)、(11.46±3.37)d(P<0.05).治疗后,两组CRP、TNF-α、IL-6 水平均下降,且观察组CRP水平(2.21±0.68)mg/L、TNF-α水平(17.42±1.94)ng/L、IL-6 水平(3.18±0.59)ng/L均低于对照组的(4.43±1.12)mg/L、(24.59±2.85)ng/L、(5.45±0.84)ng/L(P<0.05).治疗后,两组PaO2、SaO2、PaO2/FiO2 水平均明显上升,PaCO2 水平显著下降,且观察组PaO2、SaO2、PaO2/FiO2 水平分别为(92.58±9.68)mm Hg(1 mm Hg=0.133 kPa)、(92.51±9.34)%、(316.63±30.87)mm Hg,均高于对照组的(79.47±8.53)mm Hg、(80.78±8.28)%、(267.73±25.68)mm Hg,且该组PaCO2 水平(31.51±3.25)mm Hg低于对照组的(40.85±4.13)mm Hg(P<0.05).治疗后,两组FEV1、PEF、FEV1/FVC水平均升高,且观察组FEV1(3.11±0.27)L、PEF(4.84±1.14)L/s、FEV1/FVC(75.78±7.68)%均高于对照组的(2.23±0.18)L、(3.47±0.84)L/s、(62.46±6.45)%(P<0.05).结论 对重症肺炎合并呼吸衰竭患者给予支气管肺泡灌洗辅助治疗能提高疗效,缩短机械通气治疗时间,降低患者炎性因子水平,改善血气指标,提升肺通气功能,值得推广.
Efficacy of bronchoalveolar lavage in the treatment of severe pneumonia complicated with respiratory failure and its influence on inflammatory factors and pulmonary function
Objective To explore the clinical effect of bronchoalveolar lavage in the treatment of severe pneumonia complicated with respiratory failure and its influence on inflammatory factors and pulmonary function.Methods A total of 60 patients with severe pneumonia and respiratory failure were divided into a control group and an observation group according to random number table method,with 30 cases in each group.The control group was treated with conventional treatment,and the observation group was treated with bronchoalveolar lavage on the basis of the control group.Both groups were compared in terms of clinical efficacy,duration of mechanical ventilation and intensive care unit(ICU)treatment,inflammatory factors[C-reactive protein(CRP),tumor necrosis factor-α(TNF-α),interleukin-6(IL-6)],blood gas indicators[arterial partial pressure of oxygen(PaO2),arterial partial pressure of carbon dioxide(PaCO2),blood oxygen saturation(SaO2),oxygenation index(PaO2/FiO2)]and pulmonary function indicators[forced expiratory volume in one second(FEV1),peak expiratory flow(PEF),and ratio of FEV1 to forced vital capacity(FEV1/FVC)]before and after treatment.Results The total effective rate of the observation group was higher than that of the control group(90.00%vs 66.67%,P<0.05).The duration of mechanical ventilation and ICU treatment in the observation group were(6.29±1.67)and(8.52±2.53)d,which were shorter than(8.53±2.24)and(11.46±3.37)d in the control group(P<0.05).After treatment,the levels of CRP,TNF-α and IL-6 in both groups decreased;the observation group had CRP of(2.21±0.68)mg/L,TNF-α of(17.42±1.94)ng/L and IL-6 of(3.18±0.59)ng/L,which were lower than(4.43±1.12)mg/L,(24.59±2.85)ng/L and(5.45±0.84)ng/L in the control group(P<0.05).After treatment,the levels of PaO2,SaO2,PaO2/FiO2 in both groups increased significantly,while PaCO2 level decreased significantly;the PaO2,SaO2,and PaO2/FiO2 levels in the observation group were(92.58±9.68)mm Hg(1 mm Hg=0.133 kPa),(92.51±9.34)%and(316.63±30.87)mm Hg,which were higher than(79.47±8.53)mm Hg,(80.78±8.28)%and(267.73±25.68)mm Hg in the control group;and PaCO2 level of(31.51±3.25)mm Hg was lower than(40.85±4.13)mm Hg in the control group(P<0.05).After treatment,FEV1,PEF and FEV1/FVC levels increased in both groups;and the observation group had FEV1 of(3.11±0.27)L,PEF of(4.84±1.14)L/s and FEV1/FVC of(75.78±7.68)%,which were higher than(2.23±0.18)L,(3.47±0.84)L/s and(62.46±6.45)%in the control group(P<0.05).Conclusion Application of bronchoalveolar lavage in patients with severe pneumonia and respiratory failure can improve the curative effect,shorten the duration of mechanical ventilation,lower the level of inflammatory factors in patients,improve blood gas indicators,and enhance lung ventilatory function,which is worthy of promotion.

Severe pneumoniaRespiratory failureBronchoalveolar lavageClinical efficacyInflammatory factorsPulmonary function

高洪媛

展开 >

272067 济宁市第一人民医院重症医学科

重症肺炎 呼吸衰竭 支气管肺泡灌洗 临床疗效 炎性因子 肺功能

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(3)
  • 20